Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP.

Kidney Int. 2006 May;69(9):1654-61.

2.

The renal endothelium in diabetic nephropathy.

Eleftheriadis T, Antoniadi G, Pissas G, Liakopoulos V, Stefanidis I.

Ren Fail. 2013;35(4):592-9. doi: 10.3109/0886022X.2013.773836. Epub 2013 Mar 11. Review.

PMID:
23472883
4.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Ziyadeh FN, Wolf G.

Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.

PMID:
18220694
5.

[VEGF is an essential molecule for glomerular endothelial cells and its excretion in urine might be a unique marker of glomerular injury].

Kitamoto Y, Tokunaga H, Miyamoto K, Tomita K.

Rinsho Byori. 2000 Jun;48(6):485-90. Review. Japanese.

PMID:
10897664
6.

Vascular endothelial growth factor and diabetic nephropathy.

Chen S, Ziyadeh FN.

Curr Diab Rep. 2008 Dec;8(6):470-6. Review.

PMID:
18990304
7.

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.

Schrijvers BF, Flyvbjerg A, De Vriese AS.

Kidney Int. 2004 Jun;65(6):2003-17. Review.

8.

Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A.

Carranza K, Veron D, Cercado A, Bautista N, Pozo W, Tufro A, Veron D.

Nefrologia. 2015;35(2):131-8. doi: 10.1016/j.nefro.2015.05.013. Epub 2015 Jun 23. Review. English, Spanish.

9.

Vascular growth factors play critical roles in kidney glomeruli.

Gnudi L, Benedetti S, Woolf AS, Long DA.

Clin Sci (Lond). 2015 Dec;129(12):1225-36. doi: 10.1042/CS20150403. Review.

PMID:
26561594
10.

Glomerular endothelial cell differentiation.

Ballermann BJ.

Kidney Int. 2005 May;67(5):1668-71. Review.

11.

Contribution of the endothelium to the glomerular permselectivity barrier in health and disease.

Ballermann BJ.

Nephron Physiol. 2007;106(2):p19-25. Epub 2007 Jun 6. Review.

PMID:
17570944
12.

Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier.

Eremina V, Baelde HJ, Quaggin SE.

Nephron Physiol. 2007;106(2):p32-7. Epub 2007 Jun 6. Review.

PMID:
17570946
13.

The importance of cellular VEGF bioactivity in the development of glomerular disease.

Foster RR.

Nephron Exp Nephrol. 2009;113(1):e8-e15. doi: 10.1159/000228078. Epub 2009 Jul 9. Review.

14.

Nodular lesions and mesangiolysis in diabetic nephropathy.

Wada T, Shimizu M, Yokoyama H, Iwata Y, Sakai Y, Kaneko S, Furuichi K.

Clin Exp Nephrol. 2013 Feb;17(1):3-9. doi: 10.1007/s10157-012-0711-6. Epub 2012 Oct 26. Review.

PMID:
23100177
15.

Renal microvascular assembly and repair: power and promise of molecular definition.

Takahashi T, Huynh-Do U, Daniel TO.

Kidney Int. 1998 Apr;53(4):826-35. Review.

16.

Vascular Growth Factors and Glomerular Disease.

Bartlett CS, Jeansson M, Quaggin SE.

Annu Rev Physiol. 2016;78:437-61. doi: 10.1146/annurev-physiol-021115-105412. Review.

PMID:
26863327
17.

Antiangiogenic Therapy for Diabetic Nephropathy.

Tanabe K, Maeshima Y, Sato Y, Wada J.

Biomed Res Int. 2017;2017:5724069. doi: 10.1155/2017/5724069. Epub 2017 Aug 1. Review.

18.

VEGF and the diabetic kidney: More than too much of a good thing.

Majumder S, Advani A.

J Diabetes Complications. 2017 Jan;31(1):273-279. doi: 10.1016/j.jdiacomp.2016.10.020. Epub 2016 Oct 22. Review.

PMID:
27836681
19.

Tipping the balance from angiogenesis to fibrosis in CKD.

Ballermann BJ, Obeidat M.

Kidney Int Suppl (2011). 2014 Nov;4(1):45-52. Review.

Supplemental Content

Support Center